Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. reports TrK-A inhibitors

April 22, 2016

Roche patents beta-secretase 1 inhibitors

April 22, 2016

Bristol-Myers Squibb patents NS5B inhibitors

April 21, 2016

Xuzhou Yes Biotechnology divulges TNF-alpha-binding antibodies

April 20, 2016

Merck & Co. introduces IRAK-4 inhibitors

April 20, 2016

Bristol-Myers Squibb reports AP2-associated protein kinase 1 inhibitors

April 20, 2016

Bristol-Myers Squibb discloses kallikrein B inhibitors

April 20, 2016

Merck & Co. patent describes IRAK-4 inhibitors

April 19, 2016

Hutchison MediPharma announces PI3K inhibitors

April 19, 2016

Domain Therapeutics patents metabotropic glutamate receptor modulators

April 19, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...